2-(4-Chloro-3-(trifluoromethoxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98.0%, 100mg

Arg-Asp-OH, 97.0%, 250mg

1-(4-Chlorophenyl)-7-isopropoxy-6-methoxy-2-(4-nitrophenyl)-1,2-dihydroisoquinolin-3(4H)-one, 98%, 100mg

Reaktionsgefäß, DN150, 2,0 l, zylindr.,, gradu., Temp.-Vak.-Mantel, Entleerungsventil., 1 Stück

(S)-3-(3-(Allyloxy)phenyl)-2-((tert-butoxycarbonyl)amino)propanoic acid, 95.0%, 1g

Quinolin-3-ylmethanol, 95.0%, 500mg

1-(3,4-dimethylphenyl)-3-(ethoxycarbonyl)-4,5-dihydro-1H-pyrazole-5-carboxylic acid, 95.0%, 5g

4-(4-(3-(Pyridin-2-yl)-1H-pyrazol-4-yl)pyridin-2-yl)-N-(tetrahydro-2H-pyran-4-yl)benzamide, 95%, 50mg

Cyclopropanecarboxamide, 95.0%, 1kg

2-AMINO-5-BROMO-N-ISOPROPYLNICOTINAMIDE, 95.0%, 100mg

Glycin, 250 g

2-[2-(6-Bromohexyloxy)ethoxymethyl]-1,3-dichlorobenzene, 95.0%, 5g

1,4-Dichloro-2,5-dibromobenzene, 95%, 25g